GRPR Drives Metastasis via CRABP2 and FNDC4 Pathways in Lung Adenocarcinoma.
Ontology highlight
ABSTRACT: Metastasis is a leading cause of lung adenocarcinoma (LUAD)-related mortality and presents significant challenges for treatment. The gastrin-releasing peptide receptor (GRPR), a member of the G protein-coupled receptor (GPCR) family, has an unclear role in LUAD progression. This study aimed to investigate the function and underlying mechanisms of GRPR in LUAD metastasis. Our findings revealed that GRPR levels were significantly elevated in tumor tissues, and higher GRPR expression was associated with worse overall survival outcomes. Functional assays demonstrated that GRPR overexpression enhanced LUAD cell invasion, while GRPR knockdown inhibited invasion both in vitro and in vivo. RNA sequencing and gene set enrichment analysis (GSEA) identified an enrichment of metas
SUBMITTER: Kim DG
PROVIDER: S-EPMC11674891 | biostudies-literature | 2024 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA